CD103+ tumor-resident CD8+ T cells are associated with improved survival in immunotherapy-naïve melanoma patients and expand significantly during anti-PD-1 treatment

Author(s):

Jarem Edwards, James S. Wilmott, Jason Madore, Tuba Nur Gide, Camelia Quek, Annie Tasker, Angela Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira

Details:

Clinical Cancer Research, Volume 24, Issue 13, 2018-07-01

Article Link: Click here

Affiliations:

• The University of Sydney
• Royal Prince Alfred Hospital
• The University of Sydney School of Medicine
• Royal North Shore Hospital
• Department of Microbiology & Immunology
• Melanoma Institute Australia